Grand Pharmaceutical Group Limited (HKG:0512)

Market Cap	21.01B
Revenue (ttm)	11.64B
Net Income (ttm)	2.47B
Shares Out	3.50B
EPS (ttm)	0.70
PE Ratio	8.51
Forward PE	9.84
Dividend	0.26 (4.41%)
Ex-Dividend Date	Apr 14, 2025

Volume	8,122,053
Average Volume	10,089,102
Open	6.00
Previous Close	6.00
Day's Range	5.89 - 6.11
52-Week Range	4.04 - 6.49
Beta	0.79
RSI	56.75
Earnings Date	May 19, 2025

About HKG:0512

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additive...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 11,987
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0512

Financial Performance

In 2024, HKG:0512's revenue was 11.64 billion, an increase of 10.59% compared to the previous year's 10.53 billion. Earnings were 2.47 billion, an increase of 31.30%.